Insights on the Immunohistochemistry Global Market to 2029 - by Product, Application, End-user and Region - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Immunohistochemistry Market Analysis by Product (Equipment, Antibodies, Reagents, Kits), by Application (Research, Diagnostic Applications), by End User (Academic & Research Institutes, Hospitals & Diagnostic Laboratories) and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The global immunohistochemistry (IHC) market size is estimated to be USD 2,491.8 million in 2021 and is expected to witness a CAGR of 6.87% during the forecast period.

Companies Mentioned

• Agilent Technologies Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Bio SB Inc (U.S.)
• Danaher (U.S.)
• Becton
• Dickinson and Company (U.S.)
• Biocare Medical
• LLC. (U.S.)
• Merck KGaA (Germany)
• Sakura Finetek Japan Co.
• Ltd. (Japan)
• PHC Holdings Corporation (Japan)
• Diagnostic Biosystems Inc. (U.S.)

Technologically advanced IHC solutions is a key driver for the growth of the global immunohistochemistry market. Additionally, growing R&D investments in the Immunohistochemistry (IHC) market and considered initiatives by key players to attain a larger market share in the immunohistochemistry market are some of the other drivers propelling the market growth. Nevertheless, the incidence of vague regulatory frameworks and increasing incidences of product recalls in the market in the developed economies are expected to restrain the global market growth.

By Product

Based on product, the market is segmented into equipment, antibodies, reagents, and kits. In 2021, the antibodies segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the constant use of antibodies in IHC processes for disease diagnosis and testing of drugs worldwide. Kits segment projected to grow at a profitable CAGR during the forecast period. This is attributed to their compact nature and the convenience offered while using these kits is driving the market.

By Application

Based on application, the market is divided into research and diagnostic. In 2021, the diagnostic application segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the incidence of chronic diseases is increasing demand for fast and precise diagnosis of diseases worldwide. The research application segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increase in the R&D activities by major pharmaceutical companies that results in innovation and development of new drugs which is further expected to drive the demand for IHC solutions.

By End User

Based on end user, the market is categorized into academic & research institutes, hospitals & diagnostic laboratories, and other end users. In 2021, the hospitals & diagnostic laboratories segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the growth in the demand for disease diagnosis; this is because of rising in the cases of chronic diseases worldwide. The academic & research institutes segment is anticipated to grow at a profitable CAGR during the forecast period, due to the rise in adoption of IHC solutions in research institutes for drug discovery and improvement activities have led to such lucrative growth.

Key Topics Covered:

1. Research Methodology

2. Introduction: Immunohistochemistry

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraint

4.3. Market Opportunities

4.4. Market Trends

4.5. Market Challenges

5. Market Environment Analysis

5.1. Porter's 5 Forces Analysis

5.2. PESTEL Analysis

5.3. Value Chain Analysis

5.4. SWOT Analysis

5.5. Benchmark

6. COVID-19 Impact Analysis: Immunohistochemistry Market

6.1. COVID-19: Overview

6.2. COVID-19 Impact on the Global Market

6.3. COVID-19 Impact on the Regional Markets

7. Market Analysis by Product

7.1. Equipment

7.1.1. Equipment Market Forecast, 2021-2029 (USD Million)

7.2. Antibodies

7.2.1. Antibodies Market Forecast, 2021-2029 (USD Million)

7.3. Reagents

7.3.1. Reagents Market Forecast, 2021-2029 (USD Million)

7.4. Kits

7.4.1. Kits Market Forecast, 2021-2029 (USD Million)

8. Market Analysis by Application

8.1. Drug testing

8.1.1. Drug testing Market Forecast, 2021-2029 (USD Million)

8.2. Diagnostics

8.2.1. Diagnostics Market Forecast, 2021-2029 (USD Million)

9. Market Analysis by End-use

9.1. Research institutes

9.1.1. Research institutes Market Forecast, 2021-2029 (USD Million)

9.2. Hospitals & diagnostics laboratories

9.2.1. Hospitals & diagnostics laboratories Market Forecast, 2021-2029 (USD Million)

9.3. Others

9.3.1. Others Market Forecast, 2021-2029 (USD Million)

10. Regional Market Analysis

10.1. Regional Market Trends

10.2. Regional Market: Comparative Analysis

11. North America Immunohistochemistry Market

12. Europe Immunohistochemistry Market

13. Asia Pacific Immunohistochemistry Market

14. Latin America Immunohistochemistry Market

15. MEA Immunohistochemistry Market

16. Competitor Analysis

16.1. Market Share Analysis, 2021 & 2029

16.2. Competitive Mapping

16.3. Key Players Market Place Analysis

16.4. Major Recent Developments

17. Company Profiles

18. Conclusion & Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/5vm3l3